首頁 > 市場調查報告書 > 醫療設備

生技設備

生物分析檢測服務市場規模、佔有率和成長分析（按分子、檢測、工作流程、應用、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900246

生物分析檢測服務市場規模、佔有率和成長分析（按分子、檢測、工作流程、應用、最終用途和地區分類）－2026-2033年產業預測

Bioanalytical Testing Services Market Size, Share, and Growth Analysis, By Molecule (Small Molecule, Large Molecule), By Test (ADME, PK), By Workflow, By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球生物分析測試服務市場規模預計在 2024 年達到 41.8 億美元，從 2025 年的 48.6 億美元成長到 2033 年的 161.4 億美元，在預測期（2026-2033 年）內複合年成長率為 16.2%。

全球生物分析檢測服務市場為製藥和生物技術公司提供評估藥物和生物製藥安全性和有效性的關鍵分析服務。這些服務在藥物研發和監管核准過程中至關重要，主要著重於檢測血液、尿液和組織等生物樣本中的藥物濃度、代謝物和生物標記。該市場由受託研究機構(CRO) 和其他服務供應商組成，他們為業界提供可靠的檢測解決方案。儘管對準確可靠的生物分析檢測的需求不斷成長，但該市場仍面臨著高昂的服務成本和缺乏標準化調查方法等挑戰。克服這些障礙對於有效地將安全有效的治療方案推向市場至關重要。

全球生物分析檢測服務市場促進因素

全球生物分析檢測服務市場的主要驅動力是藥物研發和核准流程需求的不斷成長，而這又源自於製藥和生技公司為確保產品安全性和有效性所做的努力。慢性病發病率的上升以及對個人化醫療的需求也在推動這一需求，促使企業投資於先進的調查方法。此外，監管機構對藥物檢測和生物分析檢驗的嚴格要求也促進了市場成長。創新技術和自動化在檢測流程中的應用也提高了效率，促使更多機構將這些專業服務外包。

限制全球生物分析檢測服務市場的因素

生物分析檢測，尤其是高階和專業檢測的高昂成本，對市場構成重大挑戰。這種經濟負擔會阻礙中小型製藥公司和研究機構的發展，限制其投資必要檢測服務的能力。由於這些小規模機構通常預算緊張，這種經濟壓力會導致產業創新減少和研發週期延長。因此，生物分析檢測的高成本可能成為影響全球生物分析檢測服務市場整體成長和發展的障礙。

全球生物分析檢測服務市場趨勢

受生物標記發現和開發技術的進步推動，全球生物分析檢測服務市場正經歷顯著成長。隨著醫療重心向個人化轉變，生物標記的識別和檢驗已成為改善早期診斷和實現標靶治療的關鍵要素。最尖端科技和調查方法的融合進一步推動了這一趨勢，使生物分析檢測服務能夠更好地滿足市場對創新治療方法和診斷解決方案日益成長的需求。因此，隨著企業尋求利用這些進步來改善患者預後並簡化藥物研發流程，該市場正經歷強勁擴張。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Charles River Laboratories（USA）
Labcorp Drug Development（USA）
Eurofins Scientific（Luxembourg）
SGS SA（Switzerland）
PPD, Inc.
ICON plc（Ireland）
Syneos Health（USA）
Q2 Solutions（USA）
Intertek Group plc（UK）
Parexel International Corporation（USA）
ACM Global Laboratories（USA）
Frontage Laboratories, Inc.（USA）
BioAgilytix（USA）
KCAS Bioanalysis & Biomarker Services（USA）
Pacific BioLabs（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2157

Global Bioanalytical Testing Services Market size was valued at USD 4.18 Billion in 2024 and is poised to grow from USD 4.86 Billion in 2025 to USD 16.14 Billion by 2033, growing at a CAGR of 16.2% during the forecast period (2026-2033).

The global bioanalytical testing services market encompasses analytical offerings essential for pharmaceutical and biotech companies to evaluate the safety and efficacy of drugs and biologics. These services are vital during drug development and regulatory approval, focusing on measuring drug concentrations, metabolites, and biomarkers in biological samples such as blood, urine, and tissue. This market consists of contract research organizations (CROs) and other service providers that support the industry with reliable testing solutions. While the demand for accurate and dependable bioanalytical testing is increasing, the market faces challenges such as high service costs and a lack of standardization in methodologies. Addressing these barriers is crucial for ensuring the efficient progression of safe and effective therapeutic options to market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioanalytical Testing Services Market Segments Analysis

Global Bioanalytical Testing Services Market is segmented by Molecule, Test, Workflow, Application, End Use and region. Based on Molecule, the market is segmented into Small Molecule, Large Molecule and Others. Based on Test, the market is segmented into ADME, PK, PD, Bioavailability, Bioequivalence and Others. Based on Workflow, the market is segmented into Sample Preparation, Sample Analysis and Other Workflow Processes. Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology and Other Applications. Based on End Use, the market is segmented into Pharma & BioPharma Companies, CDMO and CRO. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioanalytical Testing Services Market

The global bioanalytical testing services market is primarily driven by the increasing demand for drug development and approval processes, as pharmaceutical and biotechnology companies seek to ensure the safety and efficacy of their products. The rise in chronic diseases and the need for personalized medicine further fuel this demand, encouraging firms to invest in advanced testing methodologies. Additionally, regulatory agencies' stringent requirements for drug testing and bioanalytical validation amplify the market's growth. The integration of innovative technologies and automation in testing procedures also enhances efficiency, thereby attracting more organizations to outsource these specialized services.

Restraints in the Global Bioanalytical Testing Services Market

The considerable expenses linked to bioanalytical testing, particularly for advanced and specialized assessments, pose a significant challenge for the market. Such financial burdens can hinder the progress of small pharmaceutical companies and research institutions, limiting their ability to invest in necessary testing services. This financial strain may lead to reduced innovation and slower development timelines within the industry, as these smaller entities often operate on tighter budgets. Consequently, the high costs of bioanalytical testing can create obstacles that impact the overall growth and advancement of the global bioanalytical testing services market.

Market Trends of the Global Bioanalytical Testing Services Market

The Global Bioanalytical Testing Services market is experiencing significant growth driven by advances in biomarker discovery and development. As the focus shifts towards personalized medicine, the identification and validation of biomarkers have emerged as critical components in enhancing early diagnosis and enabling targeted therapies. This trend is further propelled by the integration of cutting-edge technologies and methodologies, allowing bioanalytical testing services to support the burgeoning demand for innovative treatments and diagnostic solutions. Consequently, the market is witnessing a robust expansion as companies seek to leverage these advancements to improve patient outcomes and streamline drug development processes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Bioanalytical Testing Services Market Size by Molecule & CAGR (2026-2033)

Market Overview
Small Molecule
Large Molecule
- LC-MS Studies
- Immunoassays
- PK
- ADA
- Others
Others

Global Bioanalytical Testing Services Market Size by Test & CAGR (2026-2033)

Market Overview
ADME
- In-Vivo
- In-Vitro
PK
PD
Bioavailability
Bioequivalence
Others

Global Bioanalytical Testing Services Market Size by Workflow & CAGR (2026-2033)

Market Overview
Sample Preparation
- Protein Precipitation
- Liquid-Liquid Extraction
- Solid Phase Extraction
Sample Analysis
- Hyphenated technique
- Chromatographic technique
- Electrophoresis
- Ligand Binding Assay
- Mass Spectrometry
- Nuclear Magnetic Resonance
Other Workflow Processes

Global Bioanalytical Testing Services Market Size by Application & CAGR (2026-2033)

Market Overview
Oncology
Neurology
Infectious Diseases
Gastroenterology
Cardiology
Other Applications

Global Bioanalytical Testing Services Market Size by End Use & CAGR (2026-2033)

Market Overview
Pharma & BioPharma Companies
CDMO
CRO

Global Bioanalytical Testing Services Market Size & CAGR (2026-2033)

North America (Molecule, Test, Workflow, Application, End Use)
- US
- Canada
Europe (Molecule, Test, Workflow, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Molecule, Test, Workflow, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Molecule, Test, Workflow, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Molecule, Test, Workflow, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Charles River Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp Drug Development (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Q2 Solutions (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgilytix (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KCAS Bioanalysis & Biomarker Services (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific BioLabs (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments